Yahoo Web Search

Sign In

  1. Also Try

Search results

  1. investors.vrtx.comInvestor Relations | Vertex Pharmaceuticals

    1 day ago · Vertex is a biotechnology company focused on developing and commercializing treatments for serious diseases. Find out its latest financial results, events, presentations, and stock information.

  2. markets.businessinsider.com › news › stocksVertex Pharmaceuticals’ VX-880 Shows Promise in T1D Treatment...

    2 days ago · Vertex Pharmaceuticals (VRTX) Company Description: Based in Massachusetts and incorporated in 1989, Vertex Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the development ...

  3. Videos

    View all

  4. finance.yahoo.com › news › everyones-talking-vertexEveryone's Talking About Vertex Pharmaceuticals. Is It Time to...

    4 days ago · VRTX. Vertex Pharmaceuticals (NASDAQ: VRTX) recently excited the medical community with clinical trial results from an experimental diabetes treatment it's developing. In a nutshell, it looks like ...

  5. investors.vrtx.com › news-releases › news-release-detailsNews & Events - Vertex Pharmaceuticals

    2 days ago · Vertex and CRISPR Therapeutics Announce Global exa-cel Regulatory Submissions for Sickle Cell Disease and Beta Thalassemia in 2022. - Exa-cel will be submitted to the U.S. FDA for rolling review beginning in November, with completion of the U.S. submission package in Q1 2023 - - EMA and MHRA submissions are on track for Q4 2022 -

  6. www.bloomberg.com › quote › VRTX:USVRTX: Vertex Pharmaceuticals Inc Stock Price Quote - Bloomberg

    3 days ago · Stock analysis for Vertex Pharmaceuticals Inc (VRTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

    • 5.4K

  7. finance.yahoo.com › news › vertex-vx-880-shows-promiseVertex’s VX-880 shows promise in Phase I/II type 1 diabetes trial

    5 days ago · Vertex Pharmaceuticals has presented positive data from its ongoing Phase I/II clinical trial of VX-880 for the treatment of T1D. VX-880 is an investigational stem cell-derived, fully...

  8. simplywall.st › nasdaq-vrtx › vertex-pharmaceuticalsVertex Pharmaceuticals NasdaqGS:VRTX Stock Report - Simply Wall...

    5 days ago · Research Vertex Pharmaceuticals' (Nasdaq:VRTX) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.